Regeneron Pharmaceuticals, Inc. is an American biotechnology company based in Mount Pleasant, New York.
On August 19, 2020, Regeron announced a collaboration with Roche “on developing and manufacturing REGN-COV2”, Regeneron's experimental monoclonal antibody cocktail for use against COVID-19.1)